Archives
-
Nonivamide (Capsaicin Analog) Assays
2026-09-08
This scenario-based guide explains how Nonivamide (Capsaicin Analog), SKU A3278, can support reproducible TRPV1, viability, proliferation, and apoptosis workflows. It covers solvent control, stock preparation, assay interpretation, literature context, and practical product-selection criteria.
-
HR Repair Profiling Predicts Olaparib Response in MPM
2026-09-08
Borchert et al. linked homologous recombination repair defects, particularly BAP1-associated BRCAness, with olaparib sensitivity in malignant pleural mesothelioma models. Their combination of cell-line pharmacology and gene-expression profiling suggests a strategy for identifying patient subsets that may benefit from PARP inhibition, especially alongside cisplatin.
-
SCH772984 HCl: ERK1/2 Assay Guide
2026-09-07
This scenario-based guide explains how SCH772984 HCl (SKU B5866) can improve the design and interpretation of ERK-dependent viability, proliferation, and cytotoxicity assays. It covers solvent handling, controls, potency interpretation, pathway readouts, and practical criteria for selecting a reliable ERK1/2 inhibitor.
-
Brefeldin A: Reliable ER Stress Assay Workflows
2026-09-07
This scenario-driven guide explains how Brefeldin A, SKU B1400, can improve experimental reasoning in viability, proliferation, cytotoxicity, ER stress, and apoptosis workflows. It covers mechanism, assay compatibility, preparation, interpretation, and practical vendor-selection criteria without treating BFA-induced cytotoxicity as a nonspecific assay artifact.
-
Ionomycin Free Acid in FAK–TNBC Research
2026-09-05
A mechanistic and translational framework for using Ionomycin free acid to interrogate calcium-dependent regulation of the FAISL–FAK axis in triple-negative breast cancer, while distinguishing established evidence from testable experimental hypotheses.
-
Barley Leaf Senescence and Cathepsin-Like Proteases
2026-09-04
Schepetkin and Fischer show that developmental senescence in barley is accompanied by increased cathepsin B- and L-like protease activity, coordinated Rubisco loss, and induction of senescence-associated proteases. Their inhibitor, pH-profile, activity-probe, and immunoblotting strategy distinguishes broad cysteine-protease activation from the specific contribution of cathepsin B-like enzymes.
-
Meropenem trihydrate: Assay Reliability Guide
2026-09-04
A scenario-driven guide to using Meropenem trihydrate (SKU B1217) in bacterial resistance, cell viability, proliferation, and cytotoxicity workflows. It connects formulation data with practical controls and recent LC-MS/MS evidence to help researchers distinguish antimicrobial effects from assay artifacts.
-
N6-Methyl-dATP for DNA Fidelity Workflows
2026-09-03
N6-Methyl-dATP enables controlled tests of how adenine methylation affects polymerase recognition, incorporation, and replication accuracy. This workflow-focused guide connects cell-free nucleotide assays with AML transcriptional-network research while clearly separating validated evidence from hypothesis-generating applications.
-
Hexa His Tag Peptide for Cleaner Binding Assays
2026-09-03
Hexa His tag peptide enables controlled, antibody-free elution of His-tagged proteins while protecting the interpretability of interaction assays. This guide connects competitive elution with sequence-based binding analysis and practical assay design.
-
α-Amanitin: From Transcription Tool to Toxicity Map
2026-09-02
α-Amanitin is a precise RNA polymerase II perturbagen for connecting transcriptional shutdown with cell-state and toxicity phenotypes. This article shows how to use alpha-amanitin as a causal reference in pathway-aware assays, informed by recent STT3B research.
-
Live-Dead Cell Staining Kit I for Neural Assays
2026-09-02
The Live-Dead Cell Staining Kit I converts neuronal injury into a fast, two-color readout of esterase activity and membrane integrity. Use it to screen neuroprotective treatments, compare cytotoxicity, and troubleshoot injury models before committing to more specialized apoptosis or pathway assays.
-
Haloprogin: Applied Antifungal Research Workflows
2026-09-01
Haloprogin supports reproducible in vitro testing against dermatophytes, Candida, and selected Gram-positive bacteria, while its 1% topical formulations enable translational guinea pig infection models. This guide converts published MIC, MFC, formulation, and dosing parameters into practical workflows with troubleshooting checkpoints.
-
(-)-Epinephrine (+)-bitartrate: Assay Guide
2026-09-01
This scenario-based guide shows how (-)-Epinephrine (+)-bitartrate, SKU B1358, can improve the design and interpretation of cell viability, proliferation, and cytotoxicity experiments. It connects receptor pharmacology with practical decisions about concentration, solvent, storage, controls, and vendor selection.
-
Irinotecan (CPT-11): From DNA Damage to Translation
2026-08-31
A translational framework for using Irinotecan to connect SN-38 biology, colorectal cancer model selection, assay reproducibility, tumor response, and supportive-care considerations.
-
Toremifene Versus Tamoxifen in Advanced Breast Cancer
2026-08-31
This Cochrane review synthesized randomized evidence comparing two selective estrogen receptor modulators in advanced breast cancer. The analysis found no clear difference between toremifene and tamoxifen in tumor response, disease progression, overall survival, or reported adverse events, supporting treatment selection based on context rather than an assumed class-wide superiority.